Risk perception in natalizumab-treated multiple sclerosis patients and their 
neurologists

Heesen, Christoph; Kleiter, Ingo; Nguyen, Franziska; Schäffler, Nina; Kasper, Jürgen; Köpke, Sascha; Gaissmaier, Wolfgang

doi:10.1177/1352458510379819

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists

MPS-Authors

/persons/resource/persons139491

Gaissmaier, Wolfgang
Center for Adaptive Behavior and Cognition, Max Planck Institute for Human Development, Max Planck Society;
Harding Center for Risk Literacy, Max Planck Institute for Human Development, Max Planck Society;

External Resource

http://nbn-resolving.de/urn:nbn:de:bsz:352-280329
(出版社版)

https://doi.org/10.1177/1352458510379819
(出版社版)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Heesen, C., Kleiter, I., Nguyen, F., Schäffler, N., Kasper, J., Köpke, S., & Gaissmaier, W. (2010). Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists. Multiple Sclerosis, 16(12), 1507-1512. doi:10.1177/1352458510379819.

引用: https://hdl.handle.net/11858/00-001M-0000-0024-F5FF-E

要旨

要旨はありません